Christian

[Christian @iNeedADayOff]

@WOLF_Financial Crispr

[Beardo @BeardoTrader]

When the peace deal is signed, $QQQ will return to all time highs.

Jim Cramer will say earnings are up, oil is down, and it's time to be bullish again.

That's when you sell.

Then, $SPY will drop 5% and the bears will scream "DOUBLE TOP!", while everyone calls for a crash.

That's when you buy.

Trading has never been easier.

[Heisenberg @Mr_Derivatives]

-2% to -3% is a run of the mill week to week move.

-5% to -7% is a pullback.

-10% is a correction.

-15% is a deeper correction.

-20% to -25% is a bear market.

-30% to -40% is a severe bear market.

-50% is a crash.

-60% is a severe crash.

-70%+ is welcome to hell.

The $SPX is barely down 3% from ATH’s…

[lyxe @cryptolyxe]

who’s ready for 3 years of the greatest market manipulation you’ve ever seen!

[CK Capital @CKCapitalxx]

After the huge run up from many of these stocks, $KEEL is still insanely undervalued compared to peers.

$KEEL is up 35% this week and is still the cheapest AI infrastructure play on the market by a mile.

Here is the updated comparison.

$CRWV — $76B market cap. 2.9 GW contracted. Roughly $26 per watt.

$NBIS — $49B market cap. 2.5 GW contracted. Roughly $20 per watt.

$IREN — $22B market cap. 4.5 GW pipeline. Roughly $5 per watt.

$KEEL — $2.5B market cap. 2.2 GW pipeline. Roughly $1.14 per watt.

Up 35% this week and still trading at less than 5% of what CoreWeave commands per watt.

The discount exists because no hyperscaler lease is signed yet.

That is the only thing separating $KEEL from a completely different valuation framework.

One deal closes that gap.

[AdiiX @adiix_official]

🚨 do you understand what just happened someone posted the code of a Chinese Trader bot on GitHub and it was immediately deleted I managed to save it

His profile :

https://t.co/SRpsaLOGRd

Project Structure:

gabagool/
├── config/ # Configuration files
├── src/ # Core source code
├── strategies/ # Trading strategies
├── tests/ # Unit and live tests
├── backtest/ # Paper trading and simulation
├── research/ # Analysis notebooks
├── docs/ # Documentation
├── scripts/ # Utility scripts
├── logs/ # Runtime logs
├── samples/ # Reference repositories
└── requirements.txt

GitHub:

https://t.co/oD2VoSipSC

You can also copy it via :

https://t.co/uGhkwLt4cb

Save this before it gets deleted again

[Christian @iNeedADayOff]

@markgadala @elonmusk I wonder if this can be integrated into neuralink at some point

[Beat The Insider @BeatTheInsider]

🚨Insider Trade Alert🚨!

10% Owner Tempus AI, Inc. has purchased 320,267 shares in $PSNL (Personalis, Inc.) worth $2,739,181.17
$PSNL current value: $8.37
Market: NASDAQ

full disclosure:
https://t.co/OdNKE14Utm

Company Overview:
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for the detection of MRD; and NeXT Dx, a tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. In addition, the company performs whole exome sequencing of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing on human samples for research projects, such as population sequencing initiatives. Its services are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies, and for clinical trials, as well as tests are used by physicians to detect residual or recurrent cancer in patients, monitor cancer response to therapy, and uncover insights for therapy selection. The company's customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company has strategic collaboration with Tempus AI, Inc. to bring ultra-sensitive cancer recurrence testing to colorectal cancer patients. Personalis, Inc. was incorporated in 2011 and is headquartered in Fremont, California.

[bubble boi @bubbleboi]

No.. this is the market is pricing in the effect of Ozempic drugs being widespread, cheap, and administered orally.

This is a huge secular trend. I’m calling it the Girl Dinner trade. Long sexy clothing, cosmetics, & filler. Short liquid desert and fast casual salad bowl slop!

Look at the past 6 months.

[Anime Posts @animeposts]

My Hero Academia has officially ended 💔

[Wimar.X @DefiWimar]

🚨 NEXT WEEK SCHEDULE IS GIGA BULLISH!

MONDAY → QE STARTING
TUESDAY → INFLATION EXPECTATIONS
WEDNESDAY → FED RATE CUTS
THURSDAY → FED BALANCE SHEET RELEASE
FRIDAY → JEROME POWELL RESIGNS

THE BIGGEST BULL RUN STARTS NEXT WEEK!

[Christian @iNeedADayOff]

@SelfMadeMastery $laes

[InvestmentGuru @InvestmentGuru_]

These are my Top 10 high-conviction battery plays — each backed by real innovation, execution, and market-disrupting potential:

$QS – 12-min charge, 844 Wh/L energy density—PowerCo partnership = massive validation.
$AMPX – 500 Wh/kg silicon nanowire batteries—aviation and UAV game-changer with 2026 production ahead. $ENVX – 100% silicon anodes boosting energy density for AI smartphone and wearable revolution.
$NRGV – Hybrid battery-hydrogen microgrid pioneer, with a strong recurring revenue model.
$KULR – Carbon fiber thermal tech prevents fires—critical for EVs, storage, and aerospace.
$FLNC – 16GWh deployed, building a recurring SaaS moat through data and software.
$EOSE – Zinc-based, 20-year lifespan, 98% U.S. supply chain—true long-duration storage winner.
$MVST – 21V solid-state breakthrough! Targeting data centers & EVs, huge upside if factory restart confirmed.
$GWH – Iron flow batteries with 20+ year life and a $50M deal validating their chemistry.
$AMRC – North America’s top clean energy contractor with $5B+ backlog and recurring efficiency revenue.

The other $TE, $SLDP, $PLUG, $FCEL — all worth keeping on your radar as next-wave opportunities in the evolving clean energy and battery ecosystem.

[Dante 🇺🇸 @DanteTheDon]

This feels like a hundred years ago at this point

[Shay Boloor @StockSavvyShay]

15 NAMES UNDER $15B TRYING TO RIP APART THEIR INDUSTRIES

1. $TEM -- transforming diagnostics with AI
2. $OKLO-- compact nuclear energy
3. $JMIA -- Africa’s commerce infrastructure
4. $JOBY -- urban air mobility
5. $HIMS -- disrupting primary care & prescriptions
6. $ENVX -- making batteries that last longer & charge faster
7. $NVTS -- modernizing power semis for AI & EV
8. $IONQ -- pushing quantum to replace classical compute
9. $NBIS -- building an alternative to Big Cloud
10. $OSCR -- rebuilding insurance with full-stack tech
11. $EOSE -- storing clean energy w/o using lithium
12. $LMND -- automating consumer insurance
13. $ONDS -- powering drone comms
14. $PRME -- creating off-the-shelf cancer treatments
15. $ACHR -- defense-backed eVTOL deployment

[Christian @iNeedADayOff]

@HolySmokas $nbis still.

[Simeon 🇺🇸 @FTrilliams]

Whew, points were made… 🔥🔥

[Christian @iNeedADayOff]

@unusual_whales $nbis

[Christian @iNeedADayOff]

@NoLimitsRiq No Kyrie is crazy.